ClinicalTrials.Veeva

Menu
P

Professional Research Center | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cenerimod
Lunsekimig
Povetacicept
GLPG3667

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 7 total trials

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus (OPUS-1)

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to seve...

Enrolling
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Cenerimod

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to sever...

Active, not recruiting
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo

A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily fo...

Active, not recruiting
Systemic Lupus Erythematosus
Drug: GLPG3667
Drug: Placebo

This is a parallel, Phase 2/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Lunsekimig

The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserv...

Active, not recruiting
Immunoglobulin A Nephropathy
Drug: Placebo (matched to Povetacicept)
Drug: Povetacicept

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...

Enrolling
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Procedure: Sham Comparator
Biological: Renal Autologous Cell Therapy (REACT)

The purpose of this randomized study is to demonstrate direct clinical benefit, i.e., observed benefits in how humans with COPD feel in terms of symp...

Enrolling
COPD
Smoking
Other: Cigarette
Other: THS

Trial sponsors

V
G
P
P
Sanofi logo
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems